Wacker Bio licenses its E. coli based production strain to PhaseBio
Wacker licenses E. coli based production strain to PhaseBio for the manufacture of antibody fragment.
Archives for May 6, 2019
BASi acquires Smithers Avanza’s tox services business unit
Bioanalytical Systems acquires Smithers Avanza Toxicology Services business unit in response to a strong demand for its toxicology and drug disposition services.
Lundbeck set to add Abide’s chemo-proteomic platform for $400m
Lundbeck announces the acquisition of Abide, which provides the former with access to an R&D platform, a Phase II drug candidate, and drug discovery site in California.
Lonza serves small biotech with services to accelerate movement to the clinic
Lonza announces service offering to accelerate the movement of poorly-soluble small molecules into first-in-human clinical trials.
Torrent hit with two plant observations in three weeks
The Indian company announced that the US FDA issued observations for both its Indrad and Dahej facilities, as well as being required to expand its losartan recall.
WCCT adds smoking rooms at Phase I facility
WCCT adds fully compliant smoking rooms at its Phase I Clinical Unit for clinical trials testing aerosolized and inhaled products.
Sharp ‘future proofs’ manufacturing with facility investment
Sharp invests $21m to meet growing demand by expanding its capacity for packaging services at its Allentown, PA campus.